Models for Evidence Generation During the COVID-19 Pandemic: New Opportunities for Clinical Trials in Cardiovascular Medicine-Reference-Cited by-同舟云学术

Models for Evidence Generation During the COVID-19 Pandemic: New Opportunities for Clinical Trials in Cardiovascular Medicine

Published:2023-01-17 Issue:3 Volume:147 Page:187-189
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Lawler Patrick R.¹^ORCID

Affiliation:

1. Peter Munk Cardiac Centre, Toronto General Hospital; and Division of Cardiology and Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. The changing landscape of atherosclerosis

2. What Are Adaptive Platform Clinical Trials and What Role May They Have in Cardiovascular Medicine?

3. How to Use and Interpret the Results of a Platform Trial

4. Platform Trials — Beware the Noncomparable Control Group

5. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statistical considerations for cardiovascular clinical trials straddling the continuum of pandemic phases;Cardiovascular Revascularization Medicine;2024-06

2. Comparison of Bayesian and frequentist monitoring boundaries motivated by the Multiplatform Randomized Clinical Trial;Clinical Trials;2024-05-17

3. Design and Execution of Clinical Trials in the Cardiac Intensive Care Unit;Critical Care Clinics;2024-01

4. Distinct host-response signatures in circulatory shock: a narrative review;Intensive Care Medicine Experimental;2023-08-18

5. An Evolving Understanding of the Basis and Management of Vascular Complications of COVID-19: Where Do We Go From Here?;Canadian Journal of Cardiology;2023-06